Note that some links may require subscriptions.
WHO says video gaming can be addictive in the medical sense. (Newsweek)
The journal Blood‘s editors pick their top 10 papers for 2017.
A novel stereotactic radiotherapy device was cleared for use in breast cancer. (FDA)
Kmart settles litigation accusing it of overcharging government and private payers for prescription drugs.
Yes, you really are seeing more prescription drug ads on TV. (The New York Times)
Want to know exactly how the CPT coding system cheats primary care? (Kevin MD)
Patients with chronic myeloid leukemia showing a sustained response to nilotinib (Tasigna) lasting 3 years may safely stop taking the drug, according to updated label language approved by the FDA.
Meet “the physician of the future.” (STAT)
Valeant’s Bausch + Lomb subsidiary said that the FDA approved a new over-the-counter treatment for eye redness called Lumify, containing a low dose of the vasoconstrictor brimonidine.
Another win for industry, according to The New York Times: reduced fines for nursing homes that violate regulations.
Zimmer Biomet is touting results of a pilot study of a new autologous treatment for knee osteoarthritis.
Morning Break is a daily guide to what’s new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.